Cann Group
Analyst Coverage
Cannabis Investor News in-house rating · cin-analyst-v1.0
At a composite of 37, Cann Group Limited scores as Neutral, with conviction of 3 out of 5 backing the assessment. Fundamentals carry 35 percent of the model, regulatory posture 25, market signal 25, and editorial density 15, with every pillar contribution auditable. Regulatory leads the pillar table at 56, and is the main lever behind the Neutral conclusion. The offset comes from fundamentals at 23, which pulls the composite toward the middle of the band.
Working through the numbers, Cann Group Limited shows reported revenue growth of -30.1 percent year over year, an operating margin of -132.8 percent, a market cap near 7 million. Those inputs are the ones that drive the Neutral anchor rather than sentiment. All inputs are drawn from primary regulatory filings, licensed fundamentals data, institutional pricing feeds, and CIN newsroom coverage density. Because every ticker in the CIN universe is scored on the same 336-name basis, Cann Group Limited slots into a direct comparison rather than a bespoke narrative, and the score refreshes on the primary-source ingest cadence.
Regulatory posture is where the rating breathes. That pillar contributes 56, and a step-up in filing frequency without any enforcement activity would be the cleanest catalyst for a tighter reading.
- IR / PR agency
- NWR Communications
- IR email
- contact@canngrouplimited.com
- IR page
- Investor relations
- Headquarters
- 28 AYER RAJAH CRESCENT, #06-08, SINGAPORE, U0, 139959
- Phone
- 65 6305 6618
- CEO
- Mike Ryan (Interim Executive Chairman)
- CFO
- David Hine
- Auditor
- KPMG Huazhen LLP
- SEC CIK
- 1780652
- Website
- Company website
- Market cap
- $6.6M
- Enterprise value
- $20.6M
- P/E ratio
- 0.4
- Price to book
- 0.22
- Price to sales
- 0.66
- EV / EBITDA
- 0.73
- Revenue (TTM)
- $11.3M
- Gross profit (TTM)
- $5.2M
- EBITDA
- $-7.2M
- Operating margin
- -132.8%
- Profit margin
- 130.3%
- Rev growth YoY
- -30.1%
- Return on equity
- 72.6%
- Return on assets
- -13.0%
- EPS (TTM)
- $0.01
- Wall St. target price
- $5.00
- Shares outstanding
- 1,660.6M
- Insider ownership
- 22.0%
- Institutional ownership
- 3.6%
- Beta
- 0.11
- GICS sector
- Healthcare
- GICS industry
- Drug Manufacturers - Specialty & Generic
- Annual report
- Latest 10-K
- Filing portal
- ASX Announcements
Help us keep coverage accurate. Submit an update for CIN editorial review.
Bullish and Bearish Analyst Opinions for Cann Group (CAN)
Cannabis Investor News aggregates analyst coverage, price targets, insider transactions, SEC filings, and financing activity for Cann Group (CAN), a cannabis-sector equity listed on ASX. Use this profile to compare bullish and bearish opinions, monitor Form 4 insider buys and sells, and review the latest quarterly results.
Analyst average price target $1.66.
CIN editorial stance: Neutral / Wait. Mixed data profile. Risk factors: sub-$0.50, deep drawdown. (4 bullish signals, 3 bearish signals.)
Latest price: $0.21 (+9.98%) on ASX.
Historical Price Data
5-year weekly price history, intraday quotes, and 52-week range for CAN are maintained by Cannabis Investor News and refreshed throughout the trading day.